Clerkenwell Health is proud to announce the launch of its foundation course for Psychedelic-Assisted Therapy, a comprehensive 30-hour program that brings together leading experts in the field.
New 30-hour course brings together leading experts 1st May 2024, London – World-leading psychedelic clinical trials provider Clerkenwell Health is launching a new practitioner programme for healthcare professionals interested in psychedelic-assisted therapy. Clerkenwell Health’s Foundations Pro.
/CNW/ - Albert Labs International Corp. (Albert Labs (CSE: ABRT) (FSE: VB50), the "Company"), a pharmaceutical drug development company focussed on gaining.
Albert Labs International Corp (CSE:ABRT) said it has appointed Dr Sara Tai as principal investigator for its upcoming trial on KRN-101, a psilocybin-based.
US stocks rise at noon after optimistic retail earnings proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.